About My Health Careers Internship MedBlogs Contact us
Medindia LOGIN REGISTER
Advertisement

Umbilical Cord Mesenchymal Stem Cells Demonstrates Glioma-Specific Targeting Capacity

by Bidita Debnath on September 15, 2013 at 11:01 PM
Font : A-A+

 Umbilical Cord Mesenchymal Stem Cells Demonstrates Glioma-Specific Targeting Capacity

The most common ma-lignant primary brain tumor in adults is glioblastoma.

The aggressive growth manner, characterized by marked angiogenesis and extensive tumor cell invasion into normal brain parenchyma with frequent formation of tumor microsatellites at distal sites, makes eradication impossible even after extensive microsurgical resection combined with current standard chemoradiation and adjuvant temozolomide.

Advertisement

Thus, novel therapeutic strategies must to be investigated for the development of a more effective treatment strategy. Stem cell-based therapies are emerging as novel cell-based delivery vehicle for therapeutic agents.

Prof. Qingjun Zhang and team from the Department of Neurosurgery, Peking University People's Hospital proposed that umbilical cord mesenchymal stem cells may have similar targeting capabilities for glioma.
Advertisement

The researchers found that human umbilical cord mesenchymal stem cells demonstrated excellent glioma-specific targeting capacity in established rat glioma models after intratumoral injection or contralateral ventricular administration in vivo. These findings were published in the Neural Regeneration Research (Vol. 8, No. 22, 2013).

Source: Eurekalert
Advertisement

Advertisement
News A-Z
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
News Category
What's New on Medindia
Contraceptive Pills in Polycystic Ovary Syndrome (PCOS) Curtail Type 2 Diabetes Risk
Mushroom May Help Cut Down the Odds of Developing Depression
How to Battle Boredom during COVID
View all

Medindia Newsletters Subscribe to our Free Newsletters!
Terms & Conditions and Privacy Policy.

More News on:
Stem Cells - Cord Blood Stem Cells - Fundamentals Parkinsons Disease Surgical Treatment Genetics and Stem Cells Bone Marrow Transplantation Tissue Engineering and Regenerative Medicine Stem Cells Exomphalos Stem Cell Therapy 

Recommended Reading
Inflammatory Protein Converts Glioblastoma Cells into Untreatable Form
A prominent protein activated by inflammation is the key instigator that converts glioblastoma ......
Cell Maturity Pathway is Deleted or Weak in Glioblastoma Multiforme: Scientists
Scientists report that a program that pushes immature cells to grow up and fulfill their destiny as ...
Poliovirus Vaccine Trial for Recurrent Glioblastoma Reveals Promising Results
Researchers at Duke Cancer Institute report that an attack on glioblastoma brain tumor cells that .....
Researchers: Novel Combination Therapy Shuts Down Escape Route, Killing Glioblastoma Tumor Cells
Glioblastoma is the most common and lethal form of brain tumor in adults....
Bone Marrow Transplantation
Preferred Term is Hematopoietic stem cell transplantation. In this stem cell from bone marrow are in...
Exomphalos
Exomphalos is a birth disorder in which the abdominal contents herniate into the umbilical cord thro...
Stem Cell Therapy
Stem cell therapy or regenerative medicine uses undifferentiated cells for the treatment of conditio...
Stem Cells - Fundamentals
Encyclopedia section of medindia gives general info about Stem Cells...
Stem Cells - Cord Blood
Encyclopedia section of medindia gives general info about Cord Blood...
Tissue Engineering and Regenerative Medicine
This new field is an amalgamation of biology, medicine and engineering, and is believed to have mind...

Disclaimer - All information and content on this site are for information and educational purposes only. The information should not be used for either diagnosis or treatment or both for any health related problem or disease. Always seek the advice of a qualified physician for medical diagnosis and treatment. Full Disclaimer

© All Rights Reserved 1997 - 2021

This site uses cookies to deliver our services. By using our site, you acknowledge that you have read and understand our Cookie Policy, Privacy Policy, and our Terms of Use